The Announcement That Shook the Medicine Cabinet This week, President Donald Trump stood in the Roosevelt Room flanked by Health Secretary RFK Jr., claiming a link between prenatal Tylenol use and rising autism rates. Trump called it a “horrible crisis,” and RFK Jr. promised sweeping FDA warnings, label changes, and a public health campaign. FDA Commissioner Marty Makary threw in what may be the scariest bureaucratic euphemism of the year: “We now have data we cannot ignore.” He cited studies from the Boston Birth Cohort, Nurses' Health Study, and Mount Sinai-Harvard—each showing associations between acetaminophen use and developmental disorders like ADHD and autism. Sounds damning, right? But as always, the devil’s in the details. What the Data Really Shows Let’s…
Continue reading as a Citizen
Dedollarize News is free to read for signed-up members. Become a Citizen to finish this article, save what matters, and get the daily “While You Were Distracted” briefing.
No credit card required.
